SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-007647
Filing Date
2022-01-26
Accepted
2022-01-26 07:35:17
Documents
14
Period of Report
2022-01-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm224447d1_8k.htm   iXBRL 8-K 32403
2 EXHIBIT 1.1 tm224447d1_ex1-1.htm EX-1.1 221137
3 EXHIBIT 5.1 tm224447d1_ex5-1.htm EX-5.1 24379
  Complete submission text file 0001104659-22-007647.txt   508646

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aplt-20220126.xsd EX-101.SCH 3066
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aplt-20220126_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aplt-20220126_pre.xml EX-101.PRE 22617
8 EXTRACTED XBRL INSTANCE DOCUMENT tm224447d1_8k_htm.xml XML 3688
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 22555704
SIC: 2834 Pharmaceutical Preparations